Trials / Terminated
TerminatedNCT03763682
BilatEral Hypoglossal Nerve StimulaTion for TreatmEnt of ObstRuctive SLEEP Apnoea With and Without Complete Concentric Collapse
A Multicentre, Prospective, Open-label, 2 Groups Study to Assess the Safety and Performance of the Genio™ Bilateral Hypoglossal Nerve Stimulation System for the Treatment of Obstructive Sleep Apnoea in Adult Patients With and Without Complete Concentric Collapse of the Soft Palate
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- Nyxoah S.A. · Industry
- Sex
- All
- Age
- 21 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to explore the safety and performance of the Genio™ system in adult obstructive sleep apnoea (OSA) patients with and without complete concentric collapse of the soft palate over a period of 4.5 months of treatment (i.e. 6 months post-surgery) measured by the AHI, at rest to determine if there is a difference in performance between the two populations.
Detailed description
This is a prospective, open-label, multicentric, 2 groups study to assess the safety and performance of the Genio™ system in adult obstructive sleep apnoea (OSA) patients with and without complete concentric collapse of the soft palate. Participants will be consented, enrolled and eligibility criteria checked. If the participant is eligible, participant will proceed with the Genio™ IS implantation. Six (6) weeks after implantation, the implant will be activated and study visits will be scheduled at Week 7, Month 2, Month 3, Month 4, Month 5 and Month 6.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Genio(TM) bilateral hypoglossal nerve stimulation system | Subjects will be consented, enrolled and eligibility criteria checked. If the subject is eligible, subject will proceed with the Genio(TM) implant implantation. Six (6) weeks after implantation, the implant will be activated and the subject will be assessed at 1 month plus 1 week, 2, 3, 4, 5 and 6 month(s) after implantation |
Timeline
- Start date
- 2019-01-10
- Primary completion
- 2021-06-28
- Completion
- 2024-06-18
- First posted
- 2018-12-04
- Last updated
- 2025-06-06
Locations
4 sites across 1 country: Australia
Source: ClinicalTrials.gov record NCT03763682. Inclusion in this directory is not an endorsement.